Secondary Rise of Cardiac Biomarkers After Heart Attack | CK-MB Outperforms hs-cTnT in Predicting Complications

In this episode of SciBud, join host Rowan as we delve into a groundbreaking study that illuminates the behavior of cardiac biomarkers following a significant heart event known as ST-segment elevation myocardial infarction (STEMI). Discover how the markers high-sensitivity cardiac troponin T (hs-cTnT) and creatine kinase-MB (CK-MB) respond after percutaneous coronary intervention (PCI)—with intriguing findings showing that nearly 30% of patients experience a secondary rise in these biomarkers post-treatment. This episode explores the implications of these rises, revealing that CK-MB may serve as a crucial predictor of serious complications, known as major adverse cardiovascular events (MACE), while hs-cTnT behaves more cautiously. This insightful research prompts a reevaluation of monitoring practices for STEMI patients, emphasizing the need for enhanced vigilance when dual elevations are present. Join us as we unpack these findings, highlight their clinical significance, and reflect on how they may reshape patient care in the field of cardiovascular health. Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/274